Drug Shortage Report for ACT TERBINAFINE
Report ID | 111874 |
Drug Identification Number | 02254727 |
Brand name | ACT TERBINAFINE |
Common or Proper name | TERBINAFINE 250MG TABLET |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TERBINAFINE |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | D01BA |
ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-08 |
Estimated end date | |
Actual end date | 2020-05-31 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | Item is under review to be discontinued - Transitioned |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v31 | 2023-10-03 | English | Compare |
v30 | 2021-10-14 | French | Compare |
v29 | 2021-10-14 | English | Compare |
v28 | 2021-09-02 | French | Compare |
v27 | 2021-09-02 | English | Compare |
v26 | 2021-08-27 | French | Compare |
v25 | 2021-08-27 | English | Compare |
v24 | 2021-06-17 | French | Compare |
v23 | 2021-06-17 | English | Compare |
v22 | 2021-06-03 | French | Compare |
v21 | 2021-06-03 | English | Compare |
v20 | 2021-05-20 | French | Compare |
v19 | 2021-05-20 | English | Compare |
v18 | 2021-05-06 | French | Compare |
v17 | 2021-05-06 | English | Compare |
v16 | 2021-05-06 | French | Compare |
v15 | 2021-05-06 | English | Compare |
v14 | 2021-04-08 | French | Compare |
v13 | 2021-04-08 | English | Compare |
v12 | 2021-02-25 | French | Compare |